Doyle Wealth Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-148
Closed -$6K 238
2019
Q2
$6K Buy
+148
New +$6.33K ﹤0.01% 702
2019
Q1
Sell
-373
Closed -$17K 229
2018
Q4
$17K Buy
+373
New +$19.5K ﹤0.01% 534

Other funds holding AVNS

Doyle Wealth Management's AVNS Position: Q3 2019 in Review

Doyle Wealth Management sold out of Avanos Medical (AVNS) in Q3 2019, closing a stake of 148 shares — an estimated $6K sold.

Doyle Wealth Management first reported a position in AVNS in Q4 2018 and held it in 2 quarters. The position peaked at $17K in Q4 2018. 290 funds tracked by Wall St. Rank hold AVNS as of Q3 2019.

  • Doyle Wealth Management reported no remaining Avanos Medical position as of Q3 2019 after selling out during the quarter.
  • Doyle Wealth Management sold 148 Avanos Medical shares in Q3 2019, an estimated $6K.
  • Doyle Wealth Management first reported a position in Avanos Medical in Q4 2018 and held it in 2 quarters.
  • Doyle Wealth Management's Avanos Medical position peaked at $17K in Q4 2018.
  • 290 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2019.

Based on Doyle Wealth Management's 13F filing for Q3 2019, filed 5 Nov 2019.